Sprott Inc’s Pfizer PFE Stock Holding History

Sprott Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-524,470	Closed	-$16.9M	–	190
2016 Q3	$16.9M	Hold	524,470	–	–	0.6%	39
2016 Q2	$17.5M	Buy	+524,470	New	+$16.7M	0.9%	36

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sprott Inc's PFE Position: Q2 2026 in Review

Sprott Inc opened a new position in Pfizer (PFE) in Q2 2026: 9,380 shares worth $226K. The stake represents 0.01% of the portfolio and ranks #231 among its holdings. This is a return to the name: Sprott Inc previously reported a position in PFE as recently as Q4 2016.

Sprott Inc first reported a position in PFE in Q4 2013 and has held it in 14 quarters since. The position peaked at $36.1M in Q2 2016. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Sprott Inc held 9,380 shares of Pfizer worth $226K as of Q2 2026.
Pfizer was a new Sprott Inc position in Q2 2026.
Pfizer made up 0.01% of Sprott Inc's portfolio in Q2 2026, its #231 holding.
Sprott Inc first reported a position in Pfizer in Q4 2013 and has held it in 14 quarters since.
Sprott Inc's Pfizer position peaked at $36.1M in Q2 2016.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sprott Inc's 13F filing for Q2 2026, filed 28 Jul 2026.